×
About 4,870 results

ALLMedicine™ Electroconvulsive Therapy Center

Research & Reviews  1,683 results

Transcranial Direct Current Stimulation (tDCS) Therapy in Major Depression
https://clinicaltrials.gov/ct2/show/NCT04507243

May 18th, 2022 - Transcranial direct current stimulation (tDCS), a noninvasive neuromodulation technique, applied to the left dorsolateral prefrontal cortex (DLPFC) can reduce depressive symptoms and improve cognitive control in major depressive disorder (MDD). Su...

Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Reg...
https://doi.org/10.1093/schbul/sbac027
Schizophrenia Bulletin; Mishra BR, Agrawal K et. al.

May 14th, 2022 - In treatment-resistant schizophrenia (TRS), Clozapine is only approved treatment with undesirable side-effects, warranting better alternatives. Our hypothesis is acute followed by maintenance Electroconvulsive Therapy (M-ECT) will be comparable in...

Early improvement as a predictor of final remission in patients with treatment-resistan...
https://doi.org/10.1016/j.jad.2022.05.027
Journal of Affective Disorders; Zheng W, He M et. al.

May 14th, 2022 - To examine whether early symptom improvement can predict eventual remission following electroconvulsive therapy (ECT) with ketamine plus propofol (ketofol) anesthesia in patients with treatment-resistant depression (TRD). Thirty Han Chinese subjec...

The Trigeminocardiac Reflex in Electroconvulsive Therapy.
https://doi.org/10.1097/YCT.0000000000000859 10.1038/s41380-022-01516-8
The Journal of ECT; Sartorius A, Kellner CH et. al.

May 11th, 2022 - The Trigeminocardiac Reflex in Electroconvulsive Therapy.|2022|Sartorius A,Kellner CH,Karl S,|

Safe Administration of Electroconvulsive Therapy in a Patient With Catatonia and Neurop...
https://doi.org/10.1097/YCT.0000000000000862
The Journal of ECT; Baroud E, Bond JB et. al.

May 11th, 2022 - Safe Administration of Electroconvulsive Therapy in a Patient With Catatonia and Neuropsychiatric Lupus Comorbid With Fragile X Syndrome.|2022|Baroud E,Bond JB,Lucarelli J,Olusunmade M,Henry ME,|

see more →

Guidelines  2 results

Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations From Society for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236852
Journal of Neurosurgical Anesthesiology; Flexman AM, Abcejo AS et. al.

Apr 18th, 2020 - The pandemic of coronavirus disease 2019 (COVID-19) has several implications relevant to neuroanesthesiologists, including neurological manifestations of the disease, impact of anesthesia provision for specific neurosurgical procedures and electro...

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biologica...
https://doi.org/10.3109/15622975.2014.1001786
The World Journal of Biological Psychiatry : the Official... Bauer M, Severus E et. al.

Feb 14th, 2015 - These guidelines for the treatment of unipolar depressive disorders systematically review available evidence pertaining to the biological treatment of patients with major depression and produce a series of practice recommendations that are clinica...

see more →

Drugs  20 results see all →

Clinicaltrials.gov  61 results

Transcranial Direct Current Stimulation (tDCS) Therapy in Major Depression
https://clinicaltrials.gov/ct2/show/NCT04507243

May 18th, 2022 - Transcranial direct current stimulation (tDCS), a noninvasive neuromodulation technique, applied to the left dorsolateral prefrontal cortex (DLPFC) can reduce depressive symptoms and improve cognitive control in major depressive disorder (MDD). Su...

Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies
https://clinicaltrials.gov/ct2/show/NCT05210062

Apr 12th, 2022 - Acute per-anesthetic hypersensitivity reaction (HSA-PA) is a rapidly occurring systemic reaction following injection of a drug during anesthesia (mortality between 3 and 9%). The substances responsible for these reactions are different types of Ne...

Depth of Anesthesia During Electroconvulsive Therapy
https://clinicaltrials.gov/ct2/show/NCT05308056

Apr 1st, 2022 - Background Electroconvulsive therapy (ECT) is an effective therapy for severe depression where an electric current is applied to the brain to induce an epileptic seizure (1). The success of ECT is dependent upon the degree and quality of epileptic...

Epidural Cortical Stimulation for Depression
https://clinicaltrials.gov/ct2/show/NCT00565617

Mar 16th, 2022 - Hypothesis: Severely Treatment Resistant Unipolar Depressed Subjects with EpCS of medial prefrontal cortex will show a significant decrease in depression symptoms at 6 months post-implant when compared to baseline and to a matched control group tr...

The Effecay and Prediction of Deep Brain Stimulation for Treatment-resistant Depression
https://clinicaltrials.gov/ct2/show/NCT04530942

Mar 4th, 2022 - Major Depressive Disorder (MDD) is a highly prevalent psychiatric disorder, with an estimated lifetime prevalence of 14.6% across high-income countries.Effective therapeutic options for MDD include psychotherapy, different classes of antidepressan...

see more →

News  181 results

New Data Support Electroconvulsive Therapy for Depression
https://www.medscape.com/viewarticle/973918

May 12th, 2022 - Advocates and users of electroconvulsive therapy (ECT) have received further scientific backing: a retrospective cohort study has provided further evidence that ECT can prevent suicide among severely depressed patients. The patient cohort comprise...

Vagus Nerve Stimulation: A Little-Known Option for Depression
https://www.medscape.com/viewarticle/973508

May 5th, 2022 - Standard therapies for depression are antidepressants and psychotherapy. In particularly severe cases, electroconvulsive therapy (ECT) or vagus nerve stimulation (VNS) may also be indicated. VNS is an approved, effective, well-tolerated, long-term...

When is your patient a candidate for ECT?
https://www.mdedge.com/psychiatry/article/252230/major-depressive-disorder/when-your-patient-candidate-ect
Doug Brunk

Feb 25th, 2022 - LAS VEGAS – How do you know when a patient is a candidate for electroconvulsive therapy (ECT)? In the opinion of Mark S. George, MD, it depends on the level of treatment resistance, other treatments the person may be receiving for severe depressio.

Ketamine vs ECT for Depression: First Head-to-Head Results
https://www.medscape.com/viewarticle/967472

Jan 28th, 2022 - Intravenous ketamine is effective for treating depression but is inferior to electroconvulsive therapy (ECT), new research suggests. In the first head-to-head trial, ECT was more effective than IV ketamine in hospitalized patients with severe depr...

Despite the Stigma, ECT Remains a Gold Standard
https://www.medscape.com/viewarticle/966460

Jan 12th, 2022 - For Clayton Lively, electroconvulsive therapy, or ECT, has been a lifesaver. "ECT was like a last resort to treat mania and psychosis for bipolar disorder," said the 31-year-old financial firm associate who lives in Silver Spring, Maryland. "I had...

see more →

Patient Education  1 results see all →